Baker Boyer National Bank Has $252,000 Holdings in UnitedHealth Group Incorporated (UNH)

Baker Boyer National Bank continued to hold its position in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,360 shares of the healthcare conglomerate’s stock at the close of the 2nd quarter. Baker Boyer National Bank’s holdings in UnitedHealth Group were worth $252,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC increased its position in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares during the last quarter. Kings Point Capital Management increased its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the last quarter. Founders Capital Management purchased a new stake in UnitedHealth Group during the first quarter valued at $135,000. Parkside Financial Bank & Trust increased its position in UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after acquiring an additional 12 shares during the last quarter. Finally, Hanson McClain Inc. increased its position in UnitedHealth Group by 1.7% during the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after acquiring an additional 15 shares during the last quarter. Institutional investors own 86.19% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Baker Boyer National Bank Has $252,000 Holdings in UnitedHealth Group Incorporated (UNH)” was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2017/09/18/baker-boyer-national-bank-has-252000-holdings-in-unitedhealth-group-incorporated-unh.html.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.03% during trading on Monday, reaching $198.23. The company had a trading volume of 786,388 shares. The stock’s 50-day moving average price is $195.28 and its 200-day moving average price is $180.64. UnitedHealth Group Incorporated has a 52 week low of $133.03 and a 52 week high of $200.76. The company has a market capitalization of $191.66 billion, a PE ratio of 23.81 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same period in the previous year, the business earned $1.96 EPS. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.13%.

A number of analysts recently commented on the company. Cantor Fitzgerald reiterated a “buy” rating and set a $205.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 7th. Sanford C. Bernstein reiterated an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 10th. Credit Suisse Group reiterated an “outperform” rating and set a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a research report on Thursday, July 13th. Citigroup Inc. upped their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. Finally, Royal Bank Of Canada reiterated a “buy” rating and set a $212.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 20th. One equities research analyst has rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $203.41.

In other news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 25,600 shares of company stock valued at $4,962,694. 0.89% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply